# Effect of Indobufen and Aspirin on Platelet Aggregation and Long Term Prognosis in Patients With Coronary Heart Disease

> **NCT04308551** · NA · WITHDRAWN · sponsor: **Henan Institute of Cardiovascular Epidemiology**

## Conditions studied

- Stable Coronary Heart Disease

## Interventions

- **DRUG:** Indobufen
- **DRUG:** Aspirin

## Key facts

- **NCT ID:** NCT04308551
- **Lead sponsor:** Henan Institute of Cardiovascular Epidemiology
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2024-12-30
- **Primary completion:** 2026-12-30
- **Final completion:** 2026-12-30
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** shortage of funds
- **Last updated:** 2024-11-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04308551

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04308551, "Effect of Indobufen and Aspirin on Platelet Aggregation and Long Term Prognosis in Patients With Coronary Heart Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04308551. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*